Teleflex Incorporated TFX

Check out the companies making headlines yesterday:

WAYNE, Pa., September 29, 2026--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the publication of its latest peer-reviewed study in the American Journal of Infection Control demonstrating that Central Venous Catheters (CVCs) protected with Arrowg+ard™ Technology were associated with a statistically significant 70% lower hazard of central line-associated bloodstream infections (CLABSIs) compared with plain, non-impregnated catheters during a

Recently, Teleflex attracted attention as investors reacted to commentary that, despite weak constant-currency revenue growth and declining earnings metrics, some see the company as lagging broader market performance while others highlight its potential. What stands out is that new leadership and an emphasis on reducing debt are being framed as possible catalysts for a meaningful re-rating story in the eyes of investment firms. Next, we’ll examine how Teleflex’s new leadership focus and...

Shares of medical technology company Teleflex (NYSE:TFX) jumped 4.5% in the afternoon session after BofA Securities upgraded the stock from Neutral to Buy and raised its price target.

REGULATED INFORMATIONINSIDE INFORMATION Nyxoah Appoints Liam Kelly as Chief Executive Officer Further strengthening the Company’s strategic U.S. presence and focus Mont-Saint-Guibert, Belgium – September 28, 2026, 10:30 pm CET / 4:30 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced the appointment of Liam Kelly as

Even though Teleflex (currently trading at $122.08 per share) has gained 6.2% over the last six months, it has lagged the S&P 500’s 21.4% return during that period. This may have investors wondering how to approach the situation.

Teleflex (TFX) could be the next re-rating story, with its growth prospects, new leadership and pote

Wall Street analysts are making bold moves as the third quarter closes, with major calls hitting PepsiCo, Roblox, Snowflake, and a Bitcoin infrastructure stock carrying a price target that will turn heads.

Teleflex board refresh puts governance in focus Teleflex (TFX) has added veteran medical device executive Sean M. Salmon to its Board of Directors. This appointment gives investors a fresh angle on the company’s governance and its long term direction. Teleflex shares have eased in the short term, with the 7 day share price return down 4.94% and the 30 day share price return down 10.31%. The 90 day share price return of 2.34% and 1 year total shareholder return of 2.67% point to only modest...